B3GNT2 Antikörper (Internal Region)

Produktnummer ABIN238559

Produktdetails anti-B3GNT2 Antikörper

Target: B3GNT2 (UDP-GlcNAc:BetaGal beta-1,3-N-Acetylglucosaminyltransferase 2 (B3GNT2))

Bindungsspezifität: Internal Region

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser B3GNT2 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB)

Verwendungszweck: B3GNT2

Sequenz: EKHKGFRTFD IE

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Verified

Immunogen: Peptide with sequence C-EKHKGFRTFDIE, from the internal region of the protein sequence according to NP_006568.2.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

Western Blot: Approx 45 kDa band observed in Human Pancreas lysates (calculated MW of 46.0 kDa according to NP_006568.2). Recommended concentration: 0.1-0.3 μg/mL. An additional band of unknown identity was also consistently observed at 28 kDa. This band wa

Peptide ELISA: antibody detection limit dilution 1:32000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu B3GNT2

Target: B3GNT2 (UDP-GlcNAc:BetaGal beta-1,3-N-Acetylglucosaminyltransferase 2 (B3GNT2))

Andere Bezeichnung: B3GNT2 (B3GNT2 Produkte)

Synonyme: B3GN-T2 antikoerper, B3GNT antikoerper, B3GNT-2 antikoerper, B3GNT1 antikoerper, BETA3GNT antikoerper, BGNT2 antikoerper, BGnT-2 antikoerper, AA408337 antikoerper, AA409404 antikoerper, AW260308 antikoerper, B3Galt6 antikoerper, B3gnt1 antikoerper, BGnT-1 antikoerper, BGnT1 antikoerper, BGnT2 antikoerper, Beta3gnt antikoerper, MGC81185 antikoerper, B3GNT2 antikoerper, MGC179257 antikoerper, ssp5 antikoerper, wu:fa55h04 antikoerper, wu:fc39c01 antikoerper, zgc:113947 antikoerper, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 antikoerper, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 L homeolog antikoerper, beta-1,4-glucuronyltransferase 1 antikoerper, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2b antikoerper, B3GNT2 antikoerper, B3gnt2 antikoerper, b3gnt2.L antikoerper, B4GAT1 antikoerper, b3gnt2b antikoerper, b3gnt2 antikoerper

Hintergrund: B3GNT2, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 , B3GN-T1, B3GN-T2, B3GNT, B3GNT-2, B3GNT1, BETA3GNT, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1, beta-1,3-N-acetylglucosaminyltransferase bGnT-1, beta-1,3-N-a

Gen-ID: 10678, 53625

NCBI Accession: NP_006568

Pathways: Glycosaminoglycan Metabolic Process